Molecular Drivers and Precision Therapeutics in Oncology

Dear Colleagues,

Monumental discoveries (such as oncogenes, multi-step accumulation of genetic and epigenetic changes in tumorigenesis, and the hallmarks of cancer) and comprehensive analysis of datasets (such as the Cancer Genome Atlas (TCGA), the Human Tumor Atlas Network (HTAN), and the PanCancer Atlas) have paved the way for precision oncology. We are entering an era in which therapeutics based on the understanding of driver genes, oncogenic molecular signatures, tumor imaging patterns, clinical presentations, and theranostic applications will treat cancers in a more targeted and personalized manner.

We invite contributions of cutting-edge research and review articles that report the recent advancements in validating molecular drivers, utilizing software and AI tools in large database analysis, and employing targeted theranostic strategies to advance precision oncology.

Dr. Chien-An Hu
Dr. Kelly Wentz-Hunter
Topic Editors